GlassScriptPhysician profile
Tomas Paneque
NPI 1598224925
$22,620.65
in general payments reported to CMS, 2019-2025
22 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $430 · 2023: $896 · 2024: $639 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $1,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $1,970.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,680.55 | 2021-2025 | General - Bph, Lithovue, Rezum Generator |
| Cook Medical LLC | $294.37 | 2024 | Cook |
| Medtronic, INC. | $293.25 | 2021-2024 | Interstim |
| Astellas Pharma US INC | $222.68 | 2022-2025 | Xtandi |
| Olympus America INC. | $155.09 | 2022-2023 | Soltive |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $131.44 | 2021-2024 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $117.81 | 2025 | |
| Procept Biorobotics Corporation | $76.93 | 2024 | Aquabeam System |
| Intuitive Surgical, INC. | $68.73 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $67.27 | 2023 | Gemtesa |
| Pfizer INC. | $67.00 | 2021-2025 | |
| Urogen Pharma, INC. | $51.06 | 2022-2025 | |
| Tolmar, INC. | $48.74 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.96 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $36.39 | 2025 | |
| Palette Life Sciences, INC. | $23.73 | 2023 | |
| Progenics Pharmaceuticals, INC. | $22.70 | 2022 | |
| Axonics, INC. | $22.40 | 2023 | Bulkamid |
| Conmed Corporation | $21.82 | 2024 | Airseal |
| Merck Sharp & Dohme LLC | $19.12 | 2025 | Lynparza, Keytruda Qlex, Keytruda |
| Kci USA, INC. | $16.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomas Paneque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.